Posted by ABMN Staff on Apr 26th, 2024
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine ratings firms that are covering the stock, Marketbeat reports. Nine analysts have...
More of this article »